Odonate Therapeutics


Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer

Industries

Employees

11-50

Links


Org chart

Kevin C. Tang
Chairman & CEO
Collapse
Jennifer Schroeder
Vice President of Program Management and Technology
John Lemkey
Chief Operating Officer
Joseph O’Connell
Chief Medical Officer
Michael Hearne
Chief Financial Officer
Stew Kroll
Chief Development Officer
Thomas Wei
Chief Scientific Officer

Board & advisors



Offices